Innovations in artificial intelligence are transforming healthcare with tools like Delphi-2M, an AI model predicting over 1,000 disease risks decades ahead using patient health records and lifestyle data. Concurrently, biotech companies are harnessing AI to accelerate drug discovery and streamline clinical workflows. These technological strides promise significant impacts in precision medicine, early diagnosis, and therapeutic development, reflecting growing investor and research interest at intersecting digital health and biotechnology fronts.